Cargando…
Annexin-A1: Therapeutic Potential in Microvascular Disease
Annexin-A1 (ANXA1) was first discovered in the early 1980's as a protein, which mediates (some of the) anti-inflammatory effects of glucocorticoids. Subsequently, the role of ANXA1 in inflammation has been extensively studied. The biology of ANXA1 is complex and it has many different roles in b...
Autores principales: | Purvis, Gareth S. D., Solito, Egle, Thiemermann, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502989/ https://www.ncbi.nlm.nih.gov/pubmed/31114582 http://dx.doi.org/10.3389/fimmu.2019.00938 |
Ejemplares similares
-
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
por: Purvis, Gareth S. D., et al.
Publicado: (2017) -
Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes
por: Purvis, Gareth S. D., et al.
Publicado: (2019) -
Annexin A1: Uncovering the Many Talents of an Old Protein
por: Sheikh, Madeeha H., et al.
Publicado: (2018) -
The restorative role of annexin A1 at the blood–brain barrier
por: McArthur, Simon, et al.
Publicado: (2016) -
The Impact of Ageing on the CNS Immune Response in Alzheimer’s Disease
por: Chee, Stephan En Jie, et al.
Publicado: (2021)